Picture of Illumina logo

ILMN Illumina Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual cashflow statement for Illumina, fiscal year end - January 1st, USD millions except per share, conversion factor applied.

2019
December 29th
2021
January 3rd
2022
January 2nd
2023
December 31st
2023
January 1st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line990656762-1,161-4,404
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items5647-2401,3304,221
Unusual Items
Other Non-Cash Items
Changes in Working Capital-19473-152-90204
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities1,0511,080545478392
Capital Expenditures-209-189-208-196-466
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items954-365-861-35-125
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Cash from Investing Activities745-554-1,069-231-591
Financing Cash Flow Items-82-91-582-42-54
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-897-766-51-1,2101,000
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash898-232-578-963779